摘要
目的:观察胶原膜植入联合小梁切除术治疗顽固性青光眼的效果及并发症.方法:本组20例顽固性青光眼,其中新生血管性青光眼4例,先天性青光眼4例,外伤性青光眼2例,滤过手术失败青光眼10例,采用胶原膜植入联合小梁切除术,术后观察眼压及并发症.结果:术后6mo测量眼压:15.88～35.76(平均15.77±6.00)mmHg.17眼术后眼压降至21.00mmHg以下,仅3眼眼压高于21.00mmHg.未发现严重并发症及胶原膜排斥反应.结论:胶原膜植入联合小梁切除术是治疗顽固性青光眼的有效方法,尤其在基层医院可以代替昂贵的进口引流性植入物治疗顽固性青光眼.
AIM: To observe the effects and postoperative complications of trabeculectomy combined with implantation of collagen membrane for intractable glaucome.· METHODS: Twenty eyes of 20 patients with intractable glaucoma, including 4 eyes with neovascular glaucoma, 4 eyes with congenital glaucoma, 2 eyes with glaucoma secondary to trauma, 10 eyes with failed filtering surgery glaucoma, underwent trabeculectomy combined with implantation of collagen membrane. The postoperative lowering-pressure outcome and complications were observed.· RESULTS: All patients were followed-up for 6mo. The postoperative intraocular pressure was 15.88- 35.76mmHg (mean, 15.77±6.00mmHg ) at 6mo postoperation. The postoperative intraocular pressure was below 21.00 mmHg in 17 eyes, and higher than 21.00 mmHg only in 3 eyes. No serious complication or rejection related to implantation of collagen membrane occurred.· CONCLUSION: Trabeculectomy combined with implantation of collagen membrane proves to be an ideal procedure for treatment of intractable glaucoma. This surgery can replace the expensive imported drainage device implant therapy for intractable glaucoma in primary hospitals in China.
出处
《国际眼科杂志》
CAS
2004年第3期449-451,共3页
International Eye Science
基金
中国广西壮族自治区自然科学基金资助项目No.0135031)~~
